{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"semax-postherpetic","title":"Semax for Postherpetic Neuralgia: Evidence-Graded Review","body":"## What's breaking down\n\nPostherpetic neuralgia (PHN) follows shingles (herpes zoster) when the varicella-zoster virus damages sensory nerves. The virus reactivates in dorsal root ganglia, causing inflammation and neuronal injury that persists after the rash clears.\n\nKey layers include:\n- Peripheral nerve damage and ectopic firing in damaged sensory neurons.\n- Central sensitization where spinal cord and brain pain pathways amplify signals.\n- Reduced neurotrophic support as BDNF levels often decline in chronic neuropathic states.\n- Ongoing low-grade neuroinflammation that hinders natural repair.\n\nIf repair pathways stay suppressed while degeneration continues, pain becomes chronic. Standard options like gabapentin or lidocaine primarily suppress symptoms rather than target underlying nerve repair.\n\n## Why Semax might help you\n\n1. **What keeps failing:** Damaged sensory nerves after shingles show reduced BDNF signaling, impaired neuronal survival, and persistent hyperexcitability.\n2. **What Semax is studied to do:** Research in rodents shows Semax rapidly increases BDNF and NGF mRNA expression in cortex and hippocampus, supporting neuronal survival under stress and modulating neurotrophin pathways.\n3. **Therefore for you:** If the neural repair layer is part of your PHN, Semax is discussed because it is studied for building neurotrophic support rather than masking pain signals.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive repair layer via BDNF-related mechanisms. Any other interventions would address separate layers such as inflammation or symptom suppression.\n\n## What the evidence actually shows\n\nHuman data on Semax for PHN: none identified. No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.\n\nPreclinical data: Multiple rat studies demonstrate Semax induces BDNF and NGF transcription and provides neuroprotection in ischemia or hypoxia models (Dmitrieva 2009; Dolotov 2006; Medvedeva 2014). These show gene expression changes within hours but do not test viral neuropathy or chronic pain models.\n\nHuman data on Semax generally: Small Russian trials report BDNF increases and improved neurological scores in stroke patients; pilot studies note attention/memory gains in healthy volunteers. All human evidence remains limited in scale and independent replication.\n\nEvidence inventory: 0 human PHN trials; several animal BDNF/neuroprotection studies; sparse anecdotal mentions.\n\n## What scientists say\n\nResearchers note Semax modulates the BDNF/TrkB system and may support neuronal survival, yet emphasize the need for broader clinical validation outside stroke or cognitive contexts. No statements address PHN specifically.\n\n## What people say on Reddit\n\nAnecdotal mentions are rare. One user with postherpetic neuralgia suggested Semax or N-acetyl Semax as a possible option in a nootropics discussion, without reporting personal results. Other threads focus on standard PHN treatments with no Semax references.\n\n## What people say on X\n\nNo relevant posts identified linking Semax directly to postherpetic neuralgia.\n\n## What we do not know\n\nWhether Semax affects PHN pain, nerve recovery timelines, or central sensitization in humans. Optimal timing, duration, or combination effects remain unstudied. Long-term outcomes and translation from rat BDNF data to human neuropathic pain are unknown.\n\n## Safety and limits\n\nSemax appears well-tolerated in reported Russian studies with few adverse events noted, yet comprehensive Western safety data are absent. Absence of PHN-specific evidence means any application rests on mechanistic inference only.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/semax-postherpetic/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.","section":"What the evidence actually shows","tier":"human","source_ids":["web:0"],"source_status":"sourced","why_material":"Establishes the complete absence of direct clinical data for this specific use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax induces BDNF and NGF mRNA expression and supports neuronal survival under stress.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:0"],"source_status":"sourced","why_material":"Grounds the mechanistic discussion in published animal findings without overclaiming human relevance.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"One Reddit user with postherpetic neuralgia suggested Semax as a possible option without reporting personal results.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["web:20"],"source_status":"sourced","why_material":"Documents the limited anecdotal record transparently.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Small Russian human trials report BDNF increases and improved neurological scores in stroke patients after Semax.","section":"What the evidence actually shows","tier":"human","source_ids":["web:3"],"source_status":"sourced","why_material":"Clarifies the narrow scope of existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/","title":"Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophin Genes in Rat Brain","quote":"It has been suggested that the neuroprotective effects of Semax are related to neurotrophin gene expression: the rapid induction of Bdnf and Ngf mRNAs in rat ...","summary":"Rat study showing Semax induces BDNF and NGF mRNA.","claim_ids":["c2","c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.469Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"7cbd4bd18b5e77dd0635a98a431e9e361b2c2e20a27d20e86c39505301f07d43"},{"id":"web:3","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"Another study in 110 patients with stroke reported that treatment with semax (2 courses 6000 µg/day for 10 days with 20-day interval) increased plasma BDNF levels.","summary":"Summary of limited human stroke data on Semax and BDNF.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.469Z","link_status":"ok","quote_status":"unverified","prev":"7cbd4bd18b5e77dd0635a98a431e9e361b2c2e20a27d20e86c39505301f07d43","hash":"0445e1d469f5029965055c64a040fb40980671fa6576842cf1aec6c8b85d2be5"},{"id":"web:20","type":"reddit","url":"https://www.reddit.com/r/Nootropics/comments/2ve8zk/gabapentin_neurontin_and_its_moa_also/","title":"Gabapentin discussion thread","quote":"I was also diagnosed with post herpetic neuralgia (zoster sine herpete) & suggest that Semax (or N acetyl Semax ) might might help if your ...","summary":"Single anecdotal suggestion of Semax for PHN.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.469Z","link_status":"ok","quote_status":"unverified","prev":"0445e1d469f5029965055c64a040fb40980671fa6576842cf1aec6c8b85d2be5","hash":"2a4d04be370bda22872249ca879387cb59080d5649006d43fd617c7d1df3e23c"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:04:53.140Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Semax for Postherpetic Neuralgia: Evidence-Graded Review","register":"source_ledger","body":"## What's breaking down\n\nPostherpetic neuralgia (PHN) follows shingles (herpes zoster) when the varicella-zoster virus damages sensory nerves. The virus reactivates in dorsal root ganglia, causing inflammation and neuronal injury that persists after the rash clears.\n\nKey layers include:\n- Peripheral nerve damage and ectopic firing in damaged sensory neurons.\n- Central sensitization where spinal cord and brain pain pathways amplify signals.\n- Reduced neurotrophic support as BDNF levels often decline in chronic neuropathic states.\n- Ongoing low-grade neuroinflammation that hinders natural repair.\n\nIf repair pathways stay suppressed while degeneration continues, pain becomes chronic. Standard options like gabapentin or lidocaine primarily suppress symptoms rather than target underlying nerve repair.\n\n## Why Semax might help you\n\n1. **What keeps failing:** Damaged sensory nerves after shingles show reduced BDNF signaling, impaired neuronal survival, and persistent hyperexcitability.\n2. **What Semax is studied to do:** Research in rodents shows Semax rapidly increases BDNF and NGF mRNA expression in cortex and hippocampus, supporting neuronal survival under stress and modulating neurotrophin pathways.\n3. **Therefore for you:** If the neural repair layer is part of your PHN, Semax is discussed because it is studied for building neurotrophic support rather than masking pain signals.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive repair layer via BDNF-related mechanisms. Any other interventions would address separate layers such as inflammation or symptom suppression.\n\n## What the evidence actually shows\n\nHuman data on Semax for PHN: none identified. No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.\n\nPreclinical data: Multiple rat studies demonstrate Semax induces BDNF and NGF transcription and provides neuroprotection in ischemia or hypoxia models (Dmitrieva 2009; Dolotov 2006; Medvedeva 2014). These show gene expression changes within hours but do not test viral neuropathy or chronic pain models.\n\nHuman data on Semax generally: Small Russian trials report BDNF increases and improved neurological scores in stroke patients; pilot studies note attention/memory gains in healthy volunteers. All human evidence remains limited in scale and independent replication.\n\nEvidence inventory: 0 human PHN trials; several animal BDNF/neuroprotection studies; sparse anecdotal mentions.\n\n## What scientists say\n\nResearchers note Semax modulates the BDNF/TrkB system and may support neuronal survival, yet emphasize the need for broader clinical validation outside stroke or cognitive contexts. No statements address PHN specifically.\n\n## What people say on Reddit\n\nAnecdotal mentions are rare. One user with postherpetic neuralgia suggested Semax or N-acetyl Semax as a possible option in a nootropics discussion, without reporting personal results. Other threads focus on standard PHN treatments with no Semax references.\n\n## What people say on X\n\nNo relevant posts identified linking Semax directly to postherpetic neuralgia.\n\n## What we do not know\n\nWhether Semax affects PHN pain, nerve recovery timelines, or central sensitization in humans. Optimal timing, duration, or combination effects remain unstudied. Long-term outcomes and translation from rat BDNF data to human neuropathic pain are unknown.\n\n## Safety and limits\n\nSemax appears well-tolerated in reported Russian studies with few adverse events noted, yet comprehensive Western safety data are absent. Absence of PHN-specific evidence means any application rests on mechanistic inference only.","claims":[{"id":"c1","text":"No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.","section":"What the evidence actually shows","tier":"human","source_ids":["web:0"],"source_status":"sourced","why_material":"Establishes the complete absence of direct clinical data for this specific use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax induces BDNF and NGF mRNA expression and supports neuronal survival under stress.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:0"],"source_status":"sourced","why_material":"Grounds the mechanistic discussion in published animal findings without overclaiming human relevance.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"One Reddit user with postherpetic neuralgia suggested Semax as a possible option without reporting personal results.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["web:20"],"source_status":"sourced","why_material":"Documents the limited anecdotal record transparently.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Small Russian human trials report BDNF increases and improved neurological scores in stroke patients after Semax.","section":"What the evidence actually shows","tier":"human","source_ids":["web:3"],"source_status":"sourced","why_material":"Clarifies the narrow scope of existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/","title":"Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophin Genes in Rat Brain","quote":"It has been suggested that the neuroprotective effects of Semax are related to neurotrophin gene expression: the rapid induction of Bdnf and Ngf mRNAs in rat ...","link_status":"ok","quote_status":"unverified"},{"id":"web:3","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"Another study in 110 patients with stroke reported that treatment with semax (2 courses 6000 µg/day for 10 days with 20-day interval) increased plasma BDNF levels.","link_status":"ok","quote_status":"unverified"},{"id":"web:20","type":"reddit","url":"https://www.reddit.com/r/Nootropics/comments/2ve8zk/gabapentin_neurontin_and_its_moa_also/","title":"Gabapentin discussion thread","quote":"I was also diagnosed with post herpetic neuralgia (zoster sine herpete) & suggest that Semax (or N acetyl Semax ) might might help if your ...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":12299,"tokens_out":2499,"cost":0.02162125,"prev_hash":"genesis","hash":"10968c812467140f2e8a4b428e71ec8d06dda24e68503b933bc63a304ec2c031"}],"provenance":[{"ts":"2026-06-30T00:04:53.140Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Postherpetic\nSlug: semax-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target othe","response":"{\n  \"slug\": \"semax-postherpetic\",\n  \"title\": \"Semax for Postherpetic Neuralgia: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\n\\nPostherpetic neuralgia (PHN) follows shingles (herpes zoster) when the varicella-zoster virus damages sensory nerves. The virus reactivates in dorsal root ganglia, causing inflammation and neuronal injury that persists after the rash clears.\\n\\nKey layers include:\\n- Peripheral nerve damage and ectopic firing in damaged sensory neurons.\\n- Central sensitization where spinal cord and brain pain pathways amplify signals.\\n- Reduced neurotrophic support as BDNF levels often decline in chronic neuropathic states.\\n- Ongoing low-grade neuroinflammation that hinders natural repair.\\n\\nIf repair pathways stay suppressed while degeneration continues, pain becomes chronic. Standard options like gabapentin or lidocaine primarily suppress symptoms rather than target underlying nerve repair.\\n\\n## Why Semax might help you\\n\\n1. **What keeps failing:** Damaged sensory nerves after shingles show reduced BDNF signaling, impaired neuronal survival, and persistent hyperexcitability.\\n2. **What Semax is studied to do:** Research in rodents shows Semax rapidly increases BDNF and NGF mRNA expression in cortex and hippocampus, supporting neuronal survival under stress and modulating neurotrophin pathways.\\n3. **Therefore for you:** If the neural repair layer is part of your PHN, Semax is discussed because it is studied for building neurotrophic support rather than masking pain signals.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semax targets the neural/cognitive repair layer via BDNF-related mechanisms. Any other interventions would address separate layers such as inflammation or symptom suppression.\\n\\n## What the evidence actually shows\\n\\nHuman data on Semax for PHN: none identified. No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.\\n\\nPreclinical data: Multiple rat studies demonstrate Semax in","tokens_in":12299,"tokens_out":2499,"cost":0,"prev":"genesis","hash":"9cfe70d0773c6d249c26219d80939e3252cae3269a381017b1c2a5ee62e8f3fe"},{"ts":"2026-07-17T02:41:56.904Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-postherpetic","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9cfe70d0773c6d249c26219d80939e3252cae3269a381017b1c2a5ee62e8f3fe","hash":"dd9254a0772d6026a5ffc62c85c799a268b3571521e711bd62055421d7998e4b"}],"energy":{"passes":2,"tokens_in":12299,"tokens_out":2499,"tokens_total":14798,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"dd9254a0772d6026a5ffc62c85c799a268b3571521e711bd62055421d7998e4b"},"posted_at":"2026-06-29T21:33:18.689Z","created_at":"2026-06-29T21:33:18.689Z","updated_at":"2026-07-17T02:41:56.904Z","machine":{"shape":"article.machine/v1","slug":"semax-postherpetic","kind":"article","read":{"human":"https://miscsubjects.com/a/semax-postherpetic","json":"https://miscsubjects.com/api/articles/semax-postherpetic","bundle":"https://miscsubjects.com/api/articles/semax-postherpetic/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/semax-postherpetic/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=semax-postherpetic","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-postherpetic\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-postherpetic\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/semax-postherpetic/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"semax-postherpetic\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/semax-postherpetic | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/semax-postherpetic","json":"/api/articles/semax-postherpetic","markdown":"/api/articles/semax-postherpetic/bundle?format=markdown","skill":"/api/articles/semax-postherpetic/skill","topology":"/api/articles/semax-postherpetic/topology","versions":"/api/articles/semax-postherpetic/revisions","invocations":"/api/articles/semax-postherpetic/invocations"},"editorial_review":null,"editorial_audit":{"slug":"semax-postherpetic","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"80756fed2c8ea3561b947c18450156f8d28c4eb200748648e3a1ed257c962b7d","object":{"object_type":"article-object","identity":{"id":"article:semax-postherpetic","slug":"semax-postherpetic","title":"Semax for Postherpetic Neuralgia: Evidence-Graded Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/semax-postherpetic","role":"explain","audience":"human"},"skill":{"route":"/api/articles/semax-postherpetic/skill","role":"direct behavior","audience":"model","content":"---\nname: semax-postherpetic\ndescription: Apply the Semax for Postherpetic Neuralgia: Evidence-Graded Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Semax for Postherpetic Neuralgia: Evidence-Graded Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/semax-postherpetic). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/semax-postherpetic.\n- Read claims and relationships at /api/articles/semax-postherpetic/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Postherpetic neuralgia PHN follows shingles herpes zoster when the varicella-zoster virus damages sensory nerves. The virus reactivates in dorsal root ganglia, causing inflammation and neuronal injury that persists afte\n\n## Representations\n\n- Human: /a/semax-postherpetic\n- JSON: /api/articles/semax-postherpetic\n- Relationships: /api/articles/semax-postherpetic/topology\n- History: /api/articles/semax-postherpetic/revisions\n"},"json":{"route":"/api/articles/semax-postherpetic","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/semax-postherpetic/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","semax","postherpetic"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/semax-postherpetic/invocations?status=success","failure_events":"/api/articles/semax-postherpetic/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"semax-postherpetic","title":"Semax for Postherpetic Neuralgia: Evidence-Graded Review","body":"## What's breaking down\n\nPostherpetic neuralgia (PHN) follows shingles (herpes zoster) when the varicella-zoster virus damages sensory nerves. The virus reactivates in dorsal root ganglia, causing inflammation and neuronal injury that persists after the rash clears.\n\nKey layers include:\n- Peripheral nerve damage and ectopic firing in damaged sensory neurons.\n- Central sensitization where spinal cord and brain pain pathways amplify signals.\n- Reduced neurotrophic support as BDNF levels often decline in chronic neuropathic states.\n- Ongoing low-grade neuroinflammation that hinders natural repair.\n\nIf repair pathways stay suppressed while degeneration continues, pain becomes chronic. Standard options like gabapentin or lidocaine primarily suppress symptoms rather than target underlying nerve repair.\n\n## Why Semax might help you\n\n1. **What keeps failing:** Damaged sensory nerves after shingles show reduced BDNF signaling, impaired neuronal survival, and persistent hyperexcitability.\n2. **What Semax is studied to do:** Research in rodents shows Semax rapidly increases BDNF and NGF mRNA expression in cortex and hippocampus, supporting neuronal survival under stress and modulating neurotrophin pathways.\n3. **Therefore for you:** If the neural repair layer is part of your PHN, Semax is discussed because it is studied for building neurotrophic support rather than masking pain signals.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive repair layer via BDNF-related mechanisms. Any other interventions would address separate layers such as inflammation or symptom suppression.\n\n## What the evidence actually shows\n\nHuman data on Semax for PHN: none identified. No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.\n\nPreclinical data: Multiple rat studies demonstrate Semax induces BDNF and NGF transcription and provides neuroprotection in ischemia or hypoxia models (Dmitrieva 2009; Dolotov 2006; Medvedeva 2014). These show gene expression changes within hours but do not test viral neuropathy or chronic pain models.\n\nHuman data on Semax generally: Small Russian trials report BDNF increases and improved neurological scores in stroke patients; pilot studies note attention/memory gains in healthy volunteers. All human evidence remains limited in scale and independent replication.\n\nEvidence inventory: 0 human PHN trials; several animal BDNF/neuroprotection studies; sparse anecdotal mentions.\n\n## What scientists say\n\nResearchers note Semax modulates the BDNF/TrkB system and may support neuronal survival, yet emphasize the need for broader clinical validation outside stroke or cognitive contexts. No statements address PHN specifically.\n\n## What people say on Reddit\n\nAnecdotal mentions are rare. One user with postherpetic neuralgia suggested Semax or N-acetyl Semax as a possible option in a nootropics discussion, without reporting personal results. Other threads focus on standard PHN treatments with no Semax references.\n\n## What people say on X\n\nNo relevant posts identified linking Semax directly to postherpetic neuralgia.\n\n## What we do not know\n\nWhether Semax affects PHN pain, nerve recovery timelines, or central sensitization in humans. Optimal timing, duration, or combination effects remain unstudied. Long-term outcomes and translation from rat BDNF data to human neuropathic pain are unknown.\n\n## Safety and limits\n\nSemax appears well-tolerated in reported Russian studies with few adverse events noted, yet comprehensive Western safety data are absent. Absence of PHN-specific evidence means any application rests on mechanistic inference only.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/semax-postherpetic/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.","section":"What the evidence actually shows","tier":"human","source_ids":["web:0"],"source_status":"sourced","why_material":"Establishes the complete absence of direct clinical data for this specific use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax induces BDNF and NGF mRNA expression and supports neuronal survival under stress.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:0"],"source_status":"sourced","why_material":"Grounds the mechanistic discussion in published animal findings without overclaiming human relevance.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"One Reddit user with postherpetic neuralgia suggested Semax as a possible option without reporting personal results.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["web:20"],"source_status":"sourced","why_material":"Documents the limited anecdotal record transparently.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Small Russian human trials report BDNF increases and improved neurological scores in stroke patients after Semax.","section":"What the evidence actually shows","tier":"human","source_ids":["web:3"],"source_status":"sourced","why_material":"Clarifies the narrow scope of existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/","title":"Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophin Genes in Rat Brain","quote":"It has been suggested that the neuroprotective effects of Semax are related to neurotrophin gene expression: the rapid induction of Bdnf and Ngf mRNAs in rat ...","summary":"Rat study showing Semax induces BDNF and NGF mRNA.","claim_ids":["c2","c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.469Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"7cbd4bd18b5e77dd0635a98a431e9e361b2c2e20a27d20e86c39505301f07d43"},{"id":"web:3","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"Another study in 110 patients with stroke reported that treatment with semax (2 courses 6000 µg/day for 10 days with 20-day interval) increased plasma BDNF levels.","summary":"Summary of limited human stroke data on Semax and BDNF.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.469Z","link_status":"ok","quote_status":"unverified","prev":"7cbd4bd18b5e77dd0635a98a431e9e361b2c2e20a27d20e86c39505301f07d43","hash":"0445e1d469f5029965055c64a040fb40980671fa6576842cf1aec6c8b85d2be5"},{"id":"web:20","type":"reddit","url":"https://www.reddit.com/r/Nootropics/comments/2ve8zk/gabapentin_neurontin_and_its_moa_also/","title":"Gabapentin discussion thread","quote":"I was also diagnosed with post herpetic neuralgia (zoster sine herpete) & suggest that Semax (or N acetyl Semax ) might might help if your ...","summary":"Single anecdotal suggestion of Semax for PHN.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:04:52.469Z","link_status":"ok","quote_status":"unverified","prev":"0445e1d469f5029965055c64a040fb40980671fa6576842cf1aec6c8b85d2be5","hash":"2a4d04be370bda22872249ca879387cb59080d5649006d43fd617c7d1df3e23c"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:04:53.140Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Semax for Postherpetic Neuralgia: Evidence-Graded Review","register":"source_ledger","body":"## What's breaking down\n\nPostherpetic neuralgia (PHN) follows shingles (herpes zoster) when the varicella-zoster virus damages sensory nerves. The virus reactivates in dorsal root ganglia, causing inflammation and neuronal injury that persists after the rash clears.\n\nKey layers include:\n- Peripheral nerve damage and ectopic firing in damaged sensory neurons.\n- Central sensitization where spinal cord and brain pain pathways amplify signals.\n- Reduced neurotrophic support as BDNF levels often decline in chronic neuropathic states.\n- Ongoing low-grade neuroinflammation that hinders natural repair.\n\nIf repair pathways stay suppressed while degeneration continues, pain becomes chronic. Standard options like gabapentin or lidocaine primarily suppress symptoms rather than target underlying nerve repair.\n\n## Why Semax might help you\n\n1. **What keeps failing:** Damaged sensory nerves after shingles show reduced BDNF signaling, impaired neuronal survival, and persistent hyperexcitability.\n2. **What Semax is studied to do:** Research in rodents shows Semax rapidly increases BDNF and NGF mRNA expression in cortex and hippocampus, supporting neuronal survival under stress and modulating neurotrophin pathways.\n3. **Therefore for you:** If the neural repair layer is part of your PHN, Semax is discussed because it is studied for building neurotrophic support rather than masking pain signals.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive repair layer via BDNF-related mechanisms. Any other interventions would address separate layers such as inflammation or symptom suppression.\n\n## What the evidence actually shows\n\nHuman data on Semax for PHN: none identified. No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.\n\nPreclinical data: Multiple rat studies demonstrate Semax induces BDNF and NGF transcription and provides neuroprotection in ischemia or hypoxia models (Dmitrieva 2009; Dolotov 2006; Medvedeva 2014). These show gene expression changes within hours but do not test viral neuropathy or chronic pain models.\n\nHuman data on Semax generally: Small Russian trials report BDNF increases and improved neurological scores in stroke patients; pilot studies note attention/memory gains in healthy volunteers. All human evidence remains limited in scale and independent replication.\n\nEvidence inventory: 0 human PHN trials; several animal BDNF/neuroprotection studies; sparse anecdotal mentions.\n\n## What scientists say\n\nResearchers note Semax modulates the BDNF/TrkB system and may support neuronal survival, yet emphasize the need for broader clinical validation outside stroke or cognitive contexts. No statements address PHN specifically.\n\n## What people say on Reddit\n\nAnecdotal mentions are rare. One user with postherpetic neuralgia suggested Semax or N-acetyl Semax as a possible option in a nootropics discussion, without reporting personal results. Other threads focus on standard PHN treatments with no Semax references.\n\n## What people say on X\n\nNo relevant posts identified linking Semax directly to postherpetic neuralgia.\n\n## What we do not know\n\nWhether Semax affects PHN pain, nerve recovery timelines, or central sensitization in humans. Optimal timing, duration, or combination effects remain unstudied. Long-term outcomes and translation from rat BDNF data to human neuropathic pain are unknown.\n\n## Safety and limits\n\nSemax appears well-tolerated in reported Russian studies with few adverse events noted, yet comprehensive Western safety data are absent. Absence of PHN-specific evidence means any application rests on mechanistic inference only.","claims":[{"id":"c1","text":"No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.","section":"What the evidence actually shows","tier":"human","source_ids":["web:0"],"source_status":"sourced","why_material":"Establishes the complete absence of direct clinical data for this specific use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax induces BDNF and NGF mRNA expression and supports neuronal survival under stress.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:0"],"source_status":"sourced","why_material":"Grounds the mechanistic discussion in published animal findings without overclaiming human relevance.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"One Reddit user with postherpetic neuralgia suggested Semax as a possible option without reporting personal results.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["web:20"],"source_status":"sourced","why_material":"Documents the limited anecdotal record transparently.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Small Russian human trials report BDNF increases and improved neurological scores in stroke patients after Semax.","section":"What the evidence actually shows","tier":"human","source_ids":["web:3"],"source_status":"sourced","why_material":"Clarifies the narrow scope of existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:04:52.558Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11498467/","title":"Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophin Genes in Rat Brain","quote":"It has been suggested that the neuroprotective effects of Semax are related to neurotrophin gene expression: the rapid induction of Bdnf and Ngf mRNAs in rat ...","link_status":"ok","quote_status":"unverified"},{"id":"web:3","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"Another study in 110 patients with stroke reported that treatment with semax (2 courses 6000 µg/day for 10 days with 20-day interval) increased plasma BDNF levels.","link_status":"ok","quote_status":"unverified"},{"id":"web:20","type":"reddit","url":"https://www.reddit.com/r/Nootropics/comments/2ve8zk/gabapentin_neurontin_and_its_moa_also/","title":"Gabapentin discussion thread","quote":"I was also diagnosed with post herpetic neuralgia (zoster sine herpete) & suggest that Semax (or N acetyl Semax ) might might help if your ...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":12299,"tokens_out":2499,"cost":0.02162125,"prev_hash":"genesis","hash":"10968c812467140f2e8a4b428e71ec8d06dda24e68503b933bc63a304ec2c031"}],"provenance":[{"ts":"2026-06-30T00:04:53.140Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Postherpetic\nSlug: semax-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target othe","response":"{\n  \"slug\": \"semax-postherpetic\",\n  \"title\": \"Semax for Postherpetic Neuralgia: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\n\\nPostherpetic neuralgia (PHN) follows shingles (herpes zoster) when the varicella-zoster virus damages sensory nerves. The virus reactivates in dorsal root ganglia, causing inflammation and neuronal injury that persists after the rash clears.\\n\\nKey layers include:\\n- Peripheral nerve damage and ectopic firing in damaged sensory neurons.\\n- Central sensitization where spinal cord and brain pain pathways amplify signals.\\n- Reduced neurotrophic support as BDNF levels often decline in chronic neuropathic states.\\n- Ongoing low-grade neuroinflammation that hinders natural repair.\\n\\nIf repair pathways stay suppressed while degeneration continues, pain becomes chronic. Standard options like gabapentin or lidocaine primarily suppress symptoms rather than target underlying nerve repair.\\n\\n## Why Semax might help you\\n\\n1. **What keeps failing:** Damaged sensory nerves after shingles show reduced BDNF signaling, impaired neuronal survival, and persistent hyperexcitability.\\n2. **What Semax is studied to do:** Research in rodents shows Semax rapidly increases BDNF and NGF mRNA expression in cortex and hippocampus, supporting neuronal survival under stress and modulating neurotrophin pathways.\\n3. **Therefore for you:** If the neural repair layer is part of your PHN, Semax is discussed because it is studied for building neurotrophic support rather than masking pain signals.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semax targets the neural/cognitive repair layer via BDNF-related mechanisms. Any other interventions would address separate layers such as inflammation or symptom suppression.\\n\\n## What the evidence actually shows\\n\\nHuman data on Semax for PHN: none identified. No randomized controlled trials exist linking Semax to postherpetic neuralgia outcomes.\\n\\nPreclinical data: Multiple rat studies demonstrate Semax in","tokens_in":12299,"tokens_out":2499,"cost":0,"prev":"genesis","hash":"9cfe70d0773c6d249c26219d80939e3252cae3269a381017b1c2a5ee62e8f3fe"},{"ts":"2026-07-17T02:41:56.904Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-postherpetic","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9cfe70d0773c6d249c26219d80939e3252cae3269a381017b1c2a5ee62e8f3fe","hash":"dd9254a0772d6026a5ffc62c85c799a268b3571521e711bd62055421d7998e4b"}],"energy":{"passes":2,"tokens_in":12299,"tokens_out":2499,"tokens_total":14798,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"dd9254a0772d6026a5ffc62c85c799a268b3571521e711bd62055421d7998e4b"},"posted_at":"2026-06-29T21:33:18.689Z","created_at":"2026-06-29T21:33:18.689Z","updated_at":"2026-07-17T02:41:56.904Z","machine":{"shape":"article.machine/v1","slug":"semax-postherpetic","kind":"article","read":{"human":"https://miscsubjects.com/a/semax-postherpetic","json":"https://miscsubjects.com/api/articles/semax-postherpetic","bundle":"https://miscsubjects.com/api/articles/semax-postherpetic/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/semax-postherpetic/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=semax-postherpetic","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-postherpetic\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-postherpetic\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/semax-postherpetic/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"semax-postherpetic\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/semax-postherpetic | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/semax-postherpetic","json":"/api/articles/semax-postherpetic","markdown":"/api/articles/semax-postherpetic/bundle?format=markdown","skill":"/api/articles/semax-postherpetic/skill","topology":"/api/articles/semax-postherpetic/topology","versions":"/api/articles/semax-postherpetic/revisions","invocations":"/api/articles/semax-postherpetic/invocations"},"editorial_review":null,"editorial_audit":{"slug":"semax-postherpetic","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"80756fed2c8ea3561b947c18450156f8d28c4eb200748648e3a1ed257c962b7d"}}}